111 Inc
Research 111 Inc (YI) on Bullrun: market cap USD 19.70M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerYI
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Market capUSD 19.70M
- Financial periodQ1 2026
- RevenueCNY 2.36B
- Net income-CNY 37.04M
- Free cash flow-CNY 91.72M
- Gross margin5.3%
Valuation Snapshot
latest market cap is USD 19.70M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.80B | -CNY 3.22M | CNY 16.40M | 40.3% | -0.05 | CNY 73.07M | CNY 26.83M | -CNY 100.42M |
| FY2024 | CNY 14.40B | -CNY 64.74M | CNY 247.82M | 5.8% | -75.8 | CNY 462.29M | CNY 256.77M | -CNY 642.64M |
| FY2023 | CNY 14.95B | -CNY 392.69M | -CNY 457.07M | 5.7% | -27.64 | CNY 603.52M | CNY 443.23M | -CNY 583.45M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 19.70M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 22.19M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.36M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 13.02M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 25.15M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 29.08M | n/a | n/a | n/a |
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is 111 Inc's market cap?
111 Inc's market capitalization is USD 19.70M.
What does 111 Inc do?
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services.